IL1B and neoplasm: The formation of osteolytic lesions is mediated by osteoclasts via the release of multiple osteoclastogenic factors from tumor cells (e.g., IL-1, IL-6, IL-11, PDGF, MIP1α, TNF, M-CFS, RANKL and PTHrP) [16,17].